DCGI's Subject Expert Committee (SEC) grants 'in principle' approval to Bharat Biotech for conduct of 'Phase III superiority study & Phase III booster dose study' for its intranasal COVID vaccine; asks it to submit protocols for approval pic.twitter.com/s39HKqpRyg— ANI (@ANI) January 5, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


